Skip to main content
Year archive

Mabpharm Limited — 2021 filings

All 34 regulatory filings released by Mabpharm Limited (2181) in 2021, sourced directly from the official regulator.

34 Filings
2021 Period
2021 filings (34)
Filing Released Lang
CONNECTED TRANSACTIONS RENEWAL OF EXISTING TENANCY AGREEMENT
Regulatory Filings
2021-12-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-04 English
INSIDE INFORMATION ANNOUNCEMENT ACCEPTANCE OF THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT CMAB007 (OMALIZUMAB) BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2021-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-06 English
2021 Interim Report
Regulatory Filings
2021-09-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Regulatory Filings
2021-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
Regulatory Filings
2021-08-27 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-05 English
INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION)
Regulatory Filings
2021-07-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Regulatory Filings
2021-07-06 English
VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH SHANDONG KEXING BIOPRODUCTS CO., LTD IN RELATION TO CMAB008
Regulatory Filings
2021-06-29 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 18, 2021
Regulatory Filings
2021-06-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Regulatory Filings
2021-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings
2021-05-06 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, APRIL 30, 2021
Regulatory Filings
2021-04-30 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 18, 2021
Regulatory Filings
2021-04-21 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-21 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-21 English
2020 Annual Report
Regulatory Filings
2021-04-21 English
(1) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF CMAB807 (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE CLINICAL TRIALS AGREEMENT AND THE CDMO AGREEMENT AND (3) N
Regulatory Filings
2021-04-12 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, APRIL 30, 2021
Regulatory Filings
2021-04-12 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2021-04-12 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings
2021-04-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Regulatory Filings
2021-04-08 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
Regulatory Filings
2021-03-26 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings
2021-03-25 English
DATE OF BOARD MEETING
Regulatory Filings
2021-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Regulatory Filings
2021-03-03 English
(1) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF CMAB807 (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE CLINICAL TRIALS AGREEMENT AND THE CDMO AGREEMENT AND (3) C
Regulatory Filings
2021-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Regulatory Filings
2021-02-03 English
CHANGE OF ADDRESS OF REGISTERED OFFICE AND PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
Regulatory Filings
2021-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Regulatory Filings
2021-01-07 English